ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST

Samir Arnaout; Hanady R. Samaha; Julien Succar; Imad Bou-Akl; Khaled M. Musallam; Ali T. Taher

doi:10.4084/mjhid.2011.023

	ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST Samir Arnaout, Hanady R. Samaha, Julien Succar, Imad Bou-Akl, Khaled M. Musallam, Ali T. Taher
DOI: https://doi.org/10.4084/mjhid.2011.023
Samir Arnaout American University of Beirut, Lebanon \| sarnaout@aub.edu.lb Hanady R. Samaha American University of Beirut, Julien Succar American University of Beirut, Imad Bou-Akl American University of Beirut, Khaled M. Musallam American University of Beirut, Ali T. Taher American University of Beirut,
Abstract Several factors have been proposed to explain the persistence of a high incidence of venous thromboembolism worldwide with its associated morbidity and mortality. Underutilization of anticoagulants and failure of adherence to thromboprophylaxis guidelines are emerging global health concerns. We herein review this alarming observation with special emphasis on the Middle East region. We also discuss strategies that could help control this increasingly reported problem. Keywords thromboembolism; anticoagulation; prophylaxis; underutilization; risk-assessment; developing countries; Middle East
Full Text: PDF HTML
Submitted: 2014-06-12 16:03:01 Published: 2011-05-23 00:00:00 Search for citations in Google Scholar Related articles: Google Scholar